Immuron Limited (ASX:IMC) Reports Strong Travelan® Sales Growth
Immuron Limited (ASX: IMC) reports a 249% increase in Travelan® sales, indicating significant growth in both domestic and international markets.
Category: Healthcare
Reach Resources Limited (ASX: RR1) December 2024 Quarterly Activities Report
Reach Resources (ASX: RR1) reveals strong gold and REE potential in December 2024 quarterly activities report.
Neurizon Therapeutics Limited (ASX: NUZ) Investigational New Drug Application Update
Neurizon Therapeutics Limited announces FDA has placed its NUZ-001 IND application under clinical hold, seeking further information.
Archer Materials (ASX:AXE) Reports Debt-Free Q2 FY25 Activities and Financials
Archer Materials (ASX:AXE) reports progress in quantum projects and TMR sensor technology with a strong cash position in Q2 FY25.
Singular Health Group (ASX:SHG) Advances Remote Medical Imaging Initiative
Singular Health (ASX: SHG) confirms successful Phase 1 completion with PNS, advancing to Phase 2 in its medical imaging project.
Lynas Rare Earths Ltd (ASX:LYC) Reports Strong Q2 FY25 Results
Lynas Rare Earths Ltd (ASX:LYC) announces significant revenue growth and operational advancements for Q2 FY25 despite market challenges.
Telix Pharmaceuticals Limited (ASX:TLX) Receives European Approval for Illuccix®
Telix Pharmaceuticals Limited announces European approval for Illuccix®, paving the way for its commercial launch in prostate cancer imaging.
Connexion Mobility (ASX:CXZ) Reports Strong Q2 FY25 Performance
Connexion Mobility (ASX:CXZ) reports significant growth in Q2 FY25, with a 68% increase in net profit before tax.
Terrain Minerals Limited (ASX: TMX) Commences Drilling at Lort River Project
Terrain Minerals (ASX: TMX) has begun drilling at the Lort River Project to assess high-priority nickel-copper targets following successful surveys.
Visioneering Technologies (ASX:VTI) Announces Positive Interim Data
Visioneering Technologies (ASX:VTI) reports positive interim findings from the PROTECT trial on their NaturalVue® Multifocal 1 Day contact lenses.